Your browser doesn't support javascript.
loading
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
Van Wijmeersch, Bart; Singer, Barry A; Boster, Aaron; Broadley, Simon; Fernández, Óscar; Freedman, Mark S; Izquierdo, Guillermo; Lycke, Jan; Pozzilli, Carlo; Sharrack, Basil; Steingo, Brian; Wiendl, Heinz; Wray, Sibyl; Ziemssen, Tjalf; Chung, Luke; Margolin, David H; Thangavelu, Karthinathan; Vermersch, Patrick.
Afiliación
  • Van Wijmeersch B; Rehabilitation and MS Center Overpelt; BIOMED, Hasselt University, Hasselt, Belgium.
  • Singer BA; The MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, USA.
  • Boster A; OhioHealth Neurological Physicians, Columbus, OH, USA.
  • Broadley S; School of Medicine, Griffith University, Southport, QLD, Australia.
  • Fernández Ó; Fundación IMABIS, Hospital Universitario Carlos Haya, Málaga, Spain.
  • Freedman MS; University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Izquierdo G; Virgen Macarena University Hospital, Seville, Spain.
  • Lycke J; Institution of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Pozzilli C; Sapienza University of Rome, Rome, Italy.
  • Sharrack B; NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals, University of Sheffield, Sheffield, UK.
  • Steingo B; Fort Lauderdale Multiple Sclerosis Center, Fort Lauderdale, FL, USA.
  • Wiendl H; University of Münster, Münster, Germany.
  • Wray S; Hope Neurology PLLC, Knoxville, TN, USA.
  • Ziemssen T; Center of Clinical Neuroscience, Carl Gustav Carus University Hospital, Dresden, Germany.
  • Chung L; Sanofi, Cambridge, MA, USA.
  • Margolin DH; Sanofi, Cambridge, MA, USA; Cerevance, Boston, MA, USA.
  • Thangavelu K; Sanofi, Cambridge, MA, USA; EMD Serono, Billerica, MA, USA.
  • Vermersch P; University of Lille, INSERM U995, CHU Lille, FHU Imminent, Lille, France.
Mult Scler ; 26(13): 1719-1728, 2020 11.
Article en En | MEDLINE | ID: mdl-31675266
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Bélgica